What is Nuvation Bio's cash ratio?

Nuvation Bio (NUVB) reported cash ratio of 1.6× in Q1 2026.

How has Nuvation Bio's cash ratio changed year-over-year?

Nuvation Bio's cash ratio increased by 73.4% year-over-year, from 0.9× to 1.6×.

What is the long-term trend for Nuvation Bio's cash ratio?

Over 5 years (2020 to 2025), Nuvation Bio's cash ratio has grown at a -15.2% compound annual growth rate (CAGR), from 4.5× to 2×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Nuvation Bio NUVB Cash ratio

Cash ratio at other companies

Bristol-Myers SquibbBMY

0.5×0.0×

PfizerPFE

0.1×0.0×

Nuvalent, Inc.NUVL

2×+0.4×

ImmunomeIMNM

21.3×+12.9×

ArriVent BioPharma, Inc.AVBP

2.5×-1.4×

Arcus BiosciencesRCUS

1×0.0×

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

cash and equivalents/total current liabilities=1.6×

Based on the most recent quarter.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's cash ratio?: Nuvation Bio (NUVB) reported cash ratio of 1.6× in Q1 2026.
How has Nuvation Bio's cash ratio changed year-over-year?: Nuvation Bio's cash ratio increased by 73.4% year-over-year, from 0.9× to 1.6×.
What is the long-term trend for Nuvation Bio's cash ratio?: Over 5 years (2020 to 2025), Nuvation Bio's cash ratio has grown at a -15.2% compound annual growth rate (CAGR), from 4.5× to 2×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.